Literature DB >> 24100455

Vasculitis syndromes: Vasculitis assessments--what do patients think?

Paul A Bacon1, Tessa Sanderson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24100455     DOI： 10.1038/nrrheum.2013.150

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010).

Authors:  Debanjali Sinha; Sumantro Mondal; Arijit Nag; Alakendu Ghosh
Journal:  Rheumatology (Oxford)       Date:  2013-09-06       Impact factor: 7.580

2.  EULAR recommendations for the management of large vessel vasculitis.

Authors:  C Mukhtyar; L Guillevin; M C Cid; B Dasgupta; K de Groot; W Gross; T Hauser; B Hellmich; D Jayne; C G M Kallenberg; P A Merkel; H Raspe; C Salvarani; D G I Scott; C Stegeman; R Watts; K Westman; J Witter; H Yazici; R Luqmani
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

3.  The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Authors:  Peter A Merkel; Sibel Z Aydin; Maarten Boers; Haner Direskeneli; Karen Herlyn; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Raashid A Luqmani
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

4.  Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Michael Walsh; Chetan Mukhtyar; Alfred Mahr; Karen Herlyn; Raashid Luqmani; Peter A Merkel; David R W Jayne
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-07       Impact factor: 4.794

5.  Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective.

Authors:  Karen Herlyn; Bernhard Hellmich; Philip Seo; Peter A Merkel
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-15       Impact factor: 4.794

6.  The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases.

Authors:  Tessa C Sanderson; Sarah E Hewlett; Caroline Flurey; Emma Dures; Pamela Richards; John R Kirwan
Journal:  J Rheumatol       Date:  2011-02       Impact factor: 4.666

7.  Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).

Authors:  Ramnath Misra; Debashish Danda; Sivakumar M Rajappa; Alakendu Ghosh; Rajiva Gupta; Kurugodu M Mahendranath; Lakshmanan Jeyaseelan; Able Lawrence; Paul A Bacon
Journal:  Rheumatology (Oxford)       Date:  2013-04-16       Impact factor: 7.580

8.  Impaired quality of life, disability and mental health in Takayasu's arteritis.

Authors:  Neslihan Yilmaz; Meryem Can; Fatma Alibaz Oner; Melike Kalfa; Hakan Emmungil; Omer Karadag; Fatih Yildiz; Gezmis Kimyon; Baris Yilmazer; Vedat Gerdan; Sule Yasar Bilge; Birkan Ilhan; Veli Cobankara; Timucin Kasifoglu; Ayse Cefle; Bunyamin Kisacik; Ahmet Mesut Onat; Servet Akar; Fatos Onen; Eren Erken; Sedat Kiraz; Kenan Aksu; Gokhan Keser; Gonca Mumcu; Haner Direskeneli
Journal:  Rheumatology (Oxford)       Date:  2013-07-19       Impact factor: 7.580

9.  Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey.

Authors:  C Paterson
Journal:  BMJ       Date:  1996-04-20

10.  Developing core outcome sets for clinical trials: issues to consider.

Authors:  Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell
Journal:  Trials       Date:  2012-08-06       Impact factor: 2.279
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.